Evidence map›Paper›PMID 34985165›Full record

ArticleAddiction (Abingdon, England)2022

A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17.

Andrea H Weinberger, Katarzyna Wyka, June H Kim, Rosanna Smart, Michael Mangold, Ellen Schanzer, Melody Wu, Renee D Goodwin

Open access · greenAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Andrea H WeinbergerFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Katarzyna WykaDepartment of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, The City University of New York, New York, NY, USA.
June H KimInstitute for Implementation Science in Population Health, The City University of New York, New York, NY, USA.
Rosanna SmartPardee RAND Graduate School, Santa Monica, CA, USA.ORCID 0000-0002-1568-2097
Michael MangoldColumbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Ellen SchanzerFerkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Melody WuDepartment of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, The City University of New York, New York, NY, USA.
Renee D GoodwinDepartment of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, The City University of New York, New York, NY, USA.ORCID 0000-0003-1363-5729
City University of New York · USAlbert Einstein College of Medicine · USColumbia University · USRAND School of Public Policy · USYeshiva University · US

Funding

Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HIRAM BELTRAN-SANCHEZ · 2016 to 2026
$6.9M
Role of Depression and Anxiety in the Tobacco EpidemicR01DA020892 · NIDA · QUEENS COLLEGE · PI GOODWIN, RENEE D · 2005 to 2017
$2.4M
NICHD NIH HHS P2C HD041022NIDA NIH HHS R01 DA020892
6 · The paper itself

Abstract

aimsTo estimate the impact of recreational and medical cannabis laws (RCL, MCL) on the use of cannabis and cigarettes in the United States.

designA difference-in-difference approach was applied to data from the 2004-17 National Survey on Drug Use and Health (NSDUH).

settingUnited States.

participantsNationally representative cross-sectional survey of Americans aged 12 years and older (combined analytical sample for 2004-17, n = 783 663). MEASUREMENTS: Data on past-month use of (1) cigarettes and (2) cannabis were used to classify respondents into four groups: cigarette and cannabis co-use, cigarette-only use, cannabis-only use or no cigarette or cannabis use. State of residence was measured by self-report. MCL/RCL status came from state government websites.

findingsDifference-in-difference analyses suggest that MCL was associated with an increase in cigarette-cannabis co-use overall [adjusted odds ratio (aOR) = 1.09; 95% confidence interval (CI) = 1.02-1.16], with the greatest increases among those aged 50 years and above (aOR = 1.60; CI = 1.39-1.84), married (aOR = 1.19; CI = 1.07-1.31), non-Hispanic (NH) black (aOR = 1.14; CI = 1.02-1.07) and with a college degree or above (aOR = 1.15; CI = 1.06-1.24). MCL was associated with increases in cigarette-only use among those aged 50 years and above (aOR = 1.07; CI = 1.01-1.14) and NH black (aOR = 1.16; CI = 1.06-1.27) and increases in cannabis-only use among those aged 50 years and above (aOR = 1.24; CI = 1.07-1.44) and widowed/divorced/separated (aOR = 1.18; CI = 1.01-1.37). RCL was associated with an increase in cannabis-only use overall (aOR = 1.21; 95% CI = 1.09-1.34), a decline in cigarette-only use overall (aOR = 0.89; 95% CI = 0.81-0.97) and increases in co-use among those who were married (aOR = 1.24; CI = 1.02-1.50) and aged 50 years and above (aOR = 1.37; CI = 1.03-1.84).

conclusionsRecreational and medical cannabis legalization have had a varying impact on the use, and co-use, of cannabis and cigarettes in the United States.

Indexed as

CannabisHallucinogensMedical MarijuanaTobacco ProductsAnalgesicsCannabinoid Receptor AgonistsCross-Sectional StudiesHumansLegislation, DrugUnited StatesAnalgesicsCannabinoid Receptor AgonistsHallucinogensMedical MarijuanaCannabisco-useepidemiologyhealth policymarijuanaNSDUHsmokingtobacco

Identifiers

PMID34985165
PMCPMC12445298
OpenAlexW4206568653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.